CYCLO3PSS CORP
10QSB, EX-27, 2001-01-16
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CYCLO3PSS CORP, 10QSB, 2001-01-16
Next: WILLBROS GROUP INC, S-8, 2001-01-16



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTS FROM
     CYCLO3PSS CORPORATION'S FINANCIAL STATEMENTS AND IS QUALIRIFED IN ITS
     ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                                   1
<CURRENCY>                                     65,206

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              FEB-28-2001
<PERIOD-START>                                 SEP-01-2000
<PERIOD-END>                                   NOV-30-2000
<EXCHANGE-RATE>                                1
<CASH>                                         65,206
<SECURITIES>                                   0
<RECEIVABLES>                                  219,214
<ALLOWANCES>                                   5,466
<INVENTORY>                                    17,930
<CURRENT-ASSETS>                               307,816
<PP&E>                                         305,539
<DEPRECIATION>                                 120,195
<TOTAL-ASSETS>                                 493,160
<CURRENT-LIABILITIES>                          1,377,990
<BONDS>                                        0
                          0
                                    363
<COMMON>                                       29,244
<OTHER-SE>                                     (914,446)
<TOTAL-LIABILITY-AND-EQUITY>                   493,160
<SALES>                                        350,041
<TOTAL-REVENUES>                               350,041
<CGS>                                          285,112
<TOTAL-COSTS>                                  1,175,785
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             (131)
<INCOME-PRETAX>                                (823,178)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (823,178)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (823,178)
<EPS-BASIC>                                  (.03)
<EPS-DILUTED>                                  (.03)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission